DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nis Register Study Comparing Seroquel and Seroquel Prolong

Information source: AstraZeneca
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Comparing Hospitalisation Time With Seroquel and Seroquel Prolong

Phase: N/A

Status: Completed

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
Yrjö Ovaskainen, Study Director, Affiliation: Medical Affairs Manager, MD, psychiatrist
Kari Hänninen, Principal Investigator, Affiliation: MD, psychiatrist


The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are: 1. To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2. To collect information on duration and number of hospitalisation days 3. Change of GAF points

Clinical Details

Official title: A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.

Study design: Observational Model: Case Control, Time Perspective: Retrospective

Primary outcome:

Hospitalisation time

Treatment practice

Secondary outcome:

Primary diagnosis

Medication at the end of hospitalisation

GAF rating points


Minimum age: N/A. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Medication: Seroquel or Seroquel Prolong

- Diagnosis: F20-F29 or F30-F31 (ICD-10)

- In-patient

Exclusion Criteria:

- None

Locations and Contacts

Research Site, Lappeenranta, Finland
Additional Information

Starting date: August 2009
Last updated: February 15, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017